Matches in SemOpenAlex for { <https://semopenalex.org/work/W129429327> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W129429327 endingPage "9" @default.
- W129429327 startingPage "1724" @default.
- W129429327 abstract "Immunosuppression with methotrexate may be useful in the treatment of Crohn's disease. We tested the efficacy of methotrexate in refractory Crohn's disease in a randomized, controlled trial.Randomized, double-blind placebo-controlled trial of methotrexate in 33 patients with steroid-dependent Crohn's disease, 33% of whom had previously failed therapy with 6-mercaptopurine. Patients were given placebo or oral methotrexate 15 mg/week, or adjusted up to 22.5 mg/week, for up to 1 year or until treatment failure. Outcome was assessed by reduction in prednisone dosage, Crohn's Disease Activity Index, hospital admission, and laboratory parameters.Four patients were dropped from the study for non-compliance and one because of intercurrent illness, and 28 patients could be evaluated. Fewer methotrexate-treated patients (6/13 or 46%) had flares of Crohn's disease as compared to placebo-treated patients (12/15 or 80%), but this did not achieve statistical significance (p<0.1). There was a non-significant trend toward an increased number of significant side effects in the methotrexate-treated patients (3/13 or 23%) as compared to the placebo-treated patients (0/15 or 0%) (p<0.2). Laboratory indices of inflammation did not differ between the two groups.The methotrexate-treated group showed a trend toward fewer Crohn's disease flares, balanced by an increased number of significant side effects." @default.
- W129429327 created "2016-06-24" @default.
- W129429327 creator A5003570473 @default.
- W129429327 creator A5008418820 @default.
- W129429327 creator A5017235604 @default.
- W129429327 creator A5037189006 @default.
- W129429327 creator A5040044383 @default.
- W129429327 creator A5044682219 @default.
- W129429327 creator A5079951047 @default.
- W129429327 date "1999-08-03" @default.
- W129429327 modified "2023-09-23" @default.
- W129429327 title "Methotrexate in Crohn's disease: results of a randomized, double-blind, placebo-controlled trial." @default.
- W129429327 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10430331" @default.
- W129429327 hasPublicationYear "1999" @default.
- W129429327 type Work @default.
- W129429327 sameAs 129429327 @default.
- W129429327 citedByCount "52" @default.
- W129429327 countsByYear W1294293272012 @default.
- W129429327 countsByYear W1294293272014 @default.
- W129429327 countsByYear W1294293272015 @default.
- W129429327 countsByYear W1294293272016 @default.
- W129429327 countsByYear W1294293272017 @default.
- W129429327 countsByYear W1294293272018 @default.
- W129429327 countsByYear W1294293272019 @default.
- W129429327 countsByYear W1294293272020 @default.
- W129429327 countsByYear W1294293272021 @default.
- W129429327 countsByYear W1294293272022 @default.
- W129429327 crossrefType "journal-article" @default.
- W129429327 hasAuthorship W129429327A5003570473 @default.
- W129429327 hasAuthorship W129429327A5008418820 @default.
- W129429327 hasAuthorship W129429327A5017235604 @default.
- W129429327 hasAuthorship W129429327A5037189006 @default.
- W129429327 hasAuthorship W129429327A5040044383 @default.
- W129429327 hasAuthorship W129429327A5044682219 @default.
- W129429327 hasAuthorship W129429327A5079951047 @default.
- W129429327 hasConcept C121332964 @default.
- W129429327 hasConcept C126322002 @default.
- W129429327 hasConcept C141071460 @default.
- W129429327 hasConcept C142424586 @default.
- W129429327 hasConcept C142724271 @default.
- W129429327 hasConcept C168563851 @default.
- W129429327 hasConcept C204787440 @default.
- W129429327 hasConcept C27081682 @default.
- W129429327 hasConcept C2776760755 @default.
- W129429327 hasConcept C2778720950 @default.
- W129429327 hasConcept C2779134260 @default.
- W129429327 hasConcept C2779280984 @default.
- W129429327 hasConcept C2781059491 @default.
- W129429327 hasConcept C71924100 @default.
- W129429327 hasConcept C87355193 @default.
- W129429327 hasConcept C90924648 @default.
- W129429327 hasConceptScore W129429327C121332964 @default.
- W129429327 hasConceptScore W129429327C126322002 @default.
- W129429327 hasConceptScore W129429327C141071460 @default.
- W129429327 hasConceptScore W129429327C142424586 @default.
- W129429327 hasConceptScore W129429327C142724271 @default.
- W129429327 hasConceptScore W129429327C168563851 @default.
- W129429327 hasConceptScore W129429327C204787440 @default.
- W129429327 hasConceptScore W129429327C27081682 @default.
- W129429327 hasConceptScore W129429327C2776760755 @default.
- W129429327 hasConceptScore W129429327C2778720950 @default.
- W129429327 hasConceptScore W129429327C2779134260 @default.
- W129429327 hasConceptScore W129429327C2779280984 @default.
- W129429327 hasConceptScore W129429327C2781059491 @default.
- W129429327 hasConceptScore W129429327C71924100 @default.
- W129429327 hasConceptScore W129429327C87355193 @default.
- W129429327 hasConceptScore W129429327C90924648 @default.
- W129429327 hasIssue "27" @default.
- W129429327 hasLocation W1294293271 @default.
- W129429327 hasOpenAccess W129429327 @default.
- W129429327 hasPrimaryLocation W1294293271 @default.
- W129429327 hasRelatedWork W1590896317 @default.
- W129429327 hasRelatedWork W1971740020 @default.
- W129429327 hasRelatedWork W2018072530 @default.
- W129429327 hasRelatedWork W2412046563 @default.
- W129429327 hasRelatedWork W2434297151 @default.
- W129429327 hasRelatedWork W2438521912 @default.
- W129429327 hasRelatedWork W2441240031 @default.
- W129429327 hasRelatedWork W2978078855 @default.
- W129429327 hasRelatedWork W4210402399 @default.
- W129429327 hasRelatedWork W2593835267 @default.
- W129429327 hasVolume "46" @default.
- W129429327 isParatext "false" @default.
- W129429327 isRetracted "false" @default.
- W129429327 magId "129429327" @default.
- W129429327 workType "article" @default.